Climb Bio (CLYM) Accounts Payables (2020 - 2026)

Climb Bio has reported Accounts Payables for 7 years, with the latest figure at $860000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 10.68% year-over-year to $860000.0; the trailing twelve-month figure through Mar 2026 stood at $860000.0 (up 10.68% YoY), and the FY2025 full-year result was $2.3 million, up 221.84% from the prior year.
• Accounts Payables for Q1 2026 stood at $860000.0, down from $2.3 million in the prior quarter.
• The five-year high for Accounts Payables was $2.3 million in Q4 2025, with the low at $21000.0 in Q2 2022.
• Historically, Accounts Payables has averaged $739705.9 across 5 years, with a median of $750000.0 in 2022.
• The largest YoY upside for Accounts Payables was 4080.95% in 2023 against a maximum downside of 91.2% in 2023.
• Climb Bio's Accounts Payables stood at $750000.0 in 2022, then slumped by 91.2% to $66000.0 in 2023, then surged by 968.18% to $705000.0 in 2024, then jumped by 221.84% to $2.3 million in 2025, then sank by 62.1% to $860000.0 in 2026.
• The last three Accounts Payables figures came in at $860000.0 (Q1 2026), $2.3 million (Q4 2025), and $477000.0 (Q3 2025), per Business Quant data.